Cargando…
Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578972/ http://dx.doi.org/10.1136/jitc-2020-001391corr1 |
| _version_ | 1784596345974161408 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8578972 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85789722021-11-19 Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer J Immunother Cancer Correction BMJ Publishing Group 2021-11-09 /pmc/articles/PMC8578972/ http://dx.doi.org/10.1136/jitc-2020-001391corr1 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer |
| title | Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer |
| title_full | Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer |
| title_fullStr | Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer |
| title_full_unstemmed | Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer |
| title_short | Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer |
| title_sort | correction: galectin-9-based immune risk score model helps to predict relapse in stage i–iii small cell lung cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578972/ http://dx.doi.org/10.1136/jitc-2020-001391corr1 |